Beta-galactosidase Market Size, Share, Growth, and Industry Analysis, By Type (Neutral Type, Acid Type), By Application (Food industry, Pharmaceutical industry, Others), and Regional Forecast to 2033

BETA-GALACTOSIDASE MARKET OVERVIEW

Beta-galactosidase Market size is anticipated to be worth USD 322.5 million in 2024 and is expected to reach USD 645 million by 2033 at a CAGR of 7.5%.

The demand is increasing with a significant application of beta-galactosidase in food and beverages and nutrient processing, pharmaceutical products, and biotechnology. Lactase also known as beta-galactosidase is an enzyme which acts to break down lactose into glucose and galactose to boost lactose metabolism in the intestines. This is especially important in extension of lactose free products since the intolerance to lactose is fairly common in the global market. Also, the role of the enzyme in the pharmaceutical industry, particularly in diagnostics and therapeutics, expands the market applicability of the enzyme. This is because consumers are demanding functional foods more than ever, there is increased growth in enzymatic technologies and increasing concerns over green manufacturing of enzymes.

GLOBAL CRISES IMPACTING BETA-GALACTOSIDASE MARKETCOVID-19 IMPACT

Beta-galactosidase Market Had a Negative Effect Due to Disruption in Supply Chain and Consumer Demand during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 outbreak affected the production and supply chain of the Beta-galactosidase Market share in terms of decline in industrial productions. A limitation of the study is that due to COVID-19 restrictions in the manufacturing and movement of enzymes, production and distribution were hampered. End-users of beta-galactosidase include food and beverage and pharmaceutical industries, both of which slowed down due to the Covid-pandemic. It became more focused on combating the consequences, which inevitably led to inapt attention towards product development and research for any breakthrough. However, the market is coming back to life as industries carry on business and work over the increasing need for enzyme products in medical and nutritional sectors.

LATEST TREND

"Adoption of Biotechnological Advancements in Beta-galactosidase Production to Drive Market Growth"

The market for the beta-galactosidase enzyme has been slowly shifting towards the development of biotechnological improvements that improve the efficiency of the enzyme and its environmental impact. Business is purchasing recombinant DNA technology in order to develop purer enzymes, with higher stability and activity. This trend can be justified by the ever increasing concern of the cost of production which has been influenced by the ever increasing need for minimization of environmental impacts. New beta-galactosidase variants that can be specifically designed for particular industrial usages, ultra-pasteurized dairy products or biofuel production, show that this market is driven towards innovation.

BETA-GALACTOSIDASE MARKET SEGMENTATION

BY TYPE

Based on Type, the global market can be categorized into Neutral Type, Acid Type

• Neutral Type: Neutral beta-galactosidase functions best in a milieu that has a pH ranging from 6.5 to 7.5 and is especially employed in processes that require moderate conditions even for lactose hydrolysis in dairy products. It contributes to proper catalytic functions without changing the product attributes it was initially known for.

• Acid Type: Acid beta-galactosidase works optimally at slight acidic condition (pH 4.0–5.0) and therefore is suitable for processing environments that favour slight acidic conditions such as yogurt production. The compound is more stable in low pH solutions, for this reason, the application is most suitable in the food and beverages.

BY APPLICATION

Based on application, the global market can be categorized into Food industry, Pharmaceutical industry, Others

• Food industry: Beta-galactosidase is widely employed in a food industry to de-lactolise milk and other dairy products, to increase the sweetness and to improve the digestibility of milk and milk products.

• Pharmaceutical industry: In the Pharma industry, beta-galactosidase is used in formulation and diagnosis drugs, in enzyme analysis and in treatment of specific metabolic disorder.

• Others: Other uses include its use in bio fuels, biotechnology analysis and nutritional supplements; clearly identifying it as a multi-product substance.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

DRIVING FACTORS

"Rising Prevalence of Lactose Intolerance to Boost the Market"

The growing incidence of lactose intolerance is the key factor that significantly influences the Beta-galactosidase Market growth in the foreseeable future. The largest part of the world’s population, which resides in Asia, Africa and partly Latin America, suffers from lactose intolerance, which means that they cannot digest milk sugar – lactose. Beta-galactosidase enzymes are commercialized to cleave lactose into glucose and galactose subsequently for lactose-reduced or lactose-free food production. This trend is in concordance with clean labelling and the focus on incorporation of health beneficial products in the food system, thus leading to the increase in the use of beta-galactosidase in the food and beverages.

"Growth in the Biotechnology and Pharmaceutical Industries to Expand the Market"

The bio-technology and Pharma industries that are growing, fuel the beta-galactosidase market as well. Because of its functionality, the enzyme is used in enzyme replacement therapy, diagnostic tests, and biotechnological studies. In the process of biologics and therapeutics production for specific metabolic disorder the company has employed the enzyme for lactose hydrolysis. Furthermore, enhanced enzyme engineering, and recombinant DNA technologies help in deriving high yielding and pure specialized beta-galactosidase improving its applicability in pharmaceuticals and diagnostic fields. This increasing focus on biotechnology solutions analyzed in this section indicates the capacity for continuous market growth.

RESTRAINING FACTOR

"High Production Costs of Beta-galactosidase Impede Market Growth"

In addition to that; high manufacturing cost coupled with the purification of beta-galactosidase is a major factor that constrains the market’s growth. The production of enzymes involves complex biotechnological units involving fermentation, downstream processing, and quality control, which consumes many resources. Such costs may reduce the usefulness of the enzyme for small-scale application or markets that are sensitive to cost. Moreover, high purity of enzymes needed in pharmaceuticals and food industries increases the production costs which make the enzyme expensive for most people especially those in the developing world thus posing a challenge to adoption of enzyme enhanced split.

OPPORTUNITY

"Rising Demand for Lactose-Free and Plant-Based Foods to Create Opportunity for the Product in the Market"

The growth of lactose-free diets, and plant based diets are two emerging trends that are seen as providing a large growth potential for the beta-galactosidase market. So, today’s customer is really looking for dairy replacements for various reasons ranging from health to diet to ethics. Beta-galactosidase is indispensable in the formation of lactose-free dairy products and the improvement of the flavor and bioavailability of vegetarian milk alternatives. This increasing demand leads to changes in the existing manufacturing practices where they diversify and come up with new products that would meet this market of suitable and healthy meals.

CHALLENGE

"Ensuring Enzyme Stability and Efficiency across Applications Could Be a Potential Challenge "

One difficulty consists in preserving the stability and efficiency of the beta-galactosidase in various fields of application from the industry. On the issue of pH and temperature, the enzyme can be sensitive to the environment leading to an unoptimized activity of the enzyme. For example, in ultra-pasteurized dairy products or in any product containing an acidic content yielding consistent results demand specific enzyme formulations. Correcting for these issues requires investment in research and development, which may raise costs, and could make the production of high performance enzymes difficult to commercialise.

BETA-GALACTOSIDASE MARKET REGIONAL INSIGHTS

To Know Key Insights of the Market

Request Free Sample

• NORTH AMERICA (U.S. COMPULSORY)

North America especially U.S. Beta-galactosidase Market is one of the largest due to high incidences of lactose intolerance, and growing demand for lactose-free dairy products. The enzyme has already been adopted in the food and beverage line of products, which is well developed in the region to meet the consumers’ demand. Furthermore, the rising biotechnology industry and a strong Pharma sector accelerate the use of beta-galactosidase in medication production and screening. The availability of major enzyme producing companies coupled with flexible and conscious shift towards healthy diets is another factor that confirms the strong grounds of North American market. ​

• EUROPE

Europe accounts for a much larger share of the beta-galactosidase market because of the emphasis on environmental concerns and functional foods. Besides, consumers with lactose intolerance create the need for enzyme-modified dairy products and lactose-free food products in the region. Food quality and safety also have legal requirements, which in turn force them to continue developing new technologies and use beta-galactosidase in their production. The pharmaceutical industry in Europe applies the enzyme for both treatment and diagnostics, which has boosted market demand. Moreover, government policies encouraging biotechnology and environment friendly enzymes enhance the regions market potential.

• ASIA

Due to the large population of lactose intolerant people, Asia region that is consisting of China, India, and Japan is seen to be growing as the largest market for beta-galactosidase. Growing middle population base and the urbanization is also resulting in the new and innovated dairy products and functional foods. It is necessary to underline that growth of medical applications of beta-galactosidase is also caused by development of pharmaceutical and biotechnology fields in the region. Further, establishment of local production units by governments and high health awareness amongst consumers are other factors which enhance the role of Asia in the market.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market through Innovation and Market Expansion"

Some of the leading industry participants profiled in the beta-galactosidase market are DuPont de Nemours, Inc., DSM N.V., Novozymes A/S, Merck KGaA, and Amano Enzyme Inc. These companies are working for the development of the better and more efficient methods of enzyme production to fulfil the increasing demand for the beta-galactosidase in food as well as medicine and biotechnology industries. They dedicate their resources to research in order to source and create high purity, industrially relevant enzymes. Strategic partnerships, affiliation, co-alliances, acquisitions, and mergers retain and strengthen the business positions of these giants but at the same time allow them to expand through innovativeness and venturing into global new markets.

LIST OF TOP BETA-GALACTOSIDASE MARKET

• DSM (Netherlands)
• Novozymes (Denmark)
• DuPont (U.S.)
• Chr. Hansen Holding (Denmark)
• Amano Enzyme (Japan)
• Enzyme Development (U.S.)
• SternEnzym (Germany)

DSM (Netherlands)

DSM offers Tolerase® L, an acid lactase (β-galactosidase) derived from Aspergillus oryzae", with an activity level of ≥100,000 ALU/g. This enzyme is designed to aid lactose-intolerant individuals in digesting dairy products more effectively.